Search





Search





Cabaletta Bio Inc

CABA

Add to Watchlist

2.155USD

-0.065-2.93%

Close 09-24 16:00（ET）

351.37MMarket Cap

LossP/E TTM

Cabaletta Bio Inc

2.155

-0.065-2.93%

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

CABA Cash Flow Statement

You can access the annual and quarterly cash flow statements of Cabaletta Bio Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q2

FY2019Q1

FY2018Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-36.44%-41.51M

-38.18%-42.56M

-52.85%-35.34M

-69.80%-34.51M

-46.36%-30.43M

-28.41%-30.80M

-40.58%-23.12M

-61.24%-20.32M

-74.86%-20.79M

-90.26%-23.99M

-35.59%-16.45M

-27.13%-12.60M

-3.15%-11.89M

1.57%-12.61M

-15.37%-12.13M

-18.82%-9.91M

-75.17%-11.53M

-47.74%-12.81M

-14.63%-10.52M

-66.08%-8.34M

13.90%-6.58M

-75.83%-8.67M

-16.36%-9.17M

---5.02M

-100.00%-7.64M

-117.70%-4.93M

-313.16%-7.88M

---3.82M

---2.27M

---1.91M

Net income from continuing operations

-13.05%-51.02M

-21.07%-43.52M

-28.64%-41.92M

-46.48%-44.87M

-63.50%-45.13M

-43.50%-35.94M

-56.02%-32.59M

-86.22%-30.63M

-90.53%-27.60M

-57.99%-25.05M

-33.10%-20.89M

-43.94%-16.45M

-12.22%-14.49M

-22.46%-15.85M

-12.99%-15.69M

1.15%-11.43M

-15.90%-12.91M

-33.44%-12.95M

-49.19%-13.89M

-37.73%-11.56M

-36.64%-11.14M

-29.62%-9.70M

-72.29%-9.31M

---8.39M

-142.76%-8.15M

-111.92%-7.49M

-183.62%-5.40M

---3.36M

---3.53M

---1.91M

Operating gains losses

-20.73%371.00K

-30.52%337.00K

-90.25%348.00K

-18.63%345.00K

9.86%468.00K

23.41%485.00K

962.50%3.57M

19.44%424.00K

15.14%426.00K

7.67%393.00K

-6.15%336.00K

-2.20%355.00K

55.46%370.00K

66.67%365.00K

52.99%358.00K

64.25%363.00K

46.91%238.00K

88.79%219.00K

112.73%234.00K

145.56%221.00K

107.69%162.00K

52.63%116.00K

115.69%110.00K

--90.00K

271.43%78.00K

--76.00K

--51.00K

--21.00K

--0.00

----

Other non-cash items

-6.70%4.17M

86.15%4.73M

249.81%3.58M

129.64%3.98M

217.72%4.46M

152.94%2.54M

-702.27%-2.39M

2650.00%1.73M

265.89%1.41M

85.08%1.00M

-86.75%397.00K

-23.64%-68.00K

618.92%384.00K

1231.25%543.00K

--3.00M

-558.33%-55.00K

-452.38%-74.00K

-265.52%-48.00K

-100.00%0.00

-77.36%12.00K

-25.00%21.00K

--29.00K

--38.00K

--53.00K

--28.00K

----

--0.00

----

--0.00

Change in working capital

-113.06%-531.00K

-207.55%-9.37M

-156.09%-1.61M

-92.58%215.00K

13212.90%4.07M

26.22%-3.05M

339.45%2.87M

428.83%2.90M

96.77%-31.00K

-2808.45%-4.13M

147.70%654.00K

204.18%548.00K

-72.17%-959.00K

92.30%-142.00K

-189.14%-1.37M

-135.66%-526.00K

-118.62%-557.00K

-336.17%-1.84M

215.38%1.54M

-29.73%1.48M

551.13%2.99M

-126.36%-423.00K

60.21%-1.33M

--2.10M

26.33%-663.00K

108.17%1.60M

-1083.75%-3.35M

---900.00K

--771.00K

---283.00K

-Change in prepaid expenses

74.04%-249.00K

-671.70%-409.00K

-205.71%-642.00K

-271.40%-905.00K

-258.77%-959.00K

86.55%-53.00K

85.56%-210.00K

197.24%528.00K

-6.36%604.00K

-198.99%-394.00K

-20671.43%-1.45M

-59.24%-543.00K

124.74%645.00K

327.96%398.00K

99.04%-7.00K

-155.45%-341.00K

-81.12%287.00K

-91.88%93.00K

69.69%-726.00K

-48.71%615.00K

372.40%1.52M

-6.91%1.15M

37.32%-2.40M

--1.20M

14.94%-558.00K

64.22%1.23M

-404.76%-3.82M

---656.00K

--749.00K

---757.00K

-Change in other current assets

-602.26%-934.00K

-50.00%-114.00K

-921.16%-1.55M

-380.43%-1.10M

-214.66%-133.00K

88.47%-76.00K

126.10%189.00K

23.33%-230.00K

211.54%116.00K

-4018.75%-659.00K

-683.87%-724.00K

-208.70%-300.00K

-620.00%-104.00K

97.45%-16.00K

475.76%124.00K

4700.00%276.00K

211.11%20.00K

-62700.00%-628.00K

45.00%-33.00K

-500.00%-6.00K

86.47%-18.00K

75.00%-1.00K

---60.00K

---1.00K

-575.00%-133.00K

85.71%-4.00K

----

--28.00K

---28.00K

----

-Change in other current liabilities

----

---10.00K

---906.00K

----

--0.00

Cash from non-recurring investing activities

Cash from operating activities

-36.44%-41.51M

-38.18%-42.56M

-52.85%-35.34M

-69.80%-34.51M

-46.36%-30.43M

-28.41%-30.80M

-40.58%-23.12M

-61.24%-20.32M

-74.86%-20.79M

-90.26%-23.99M

-35.59%-16.45M

-27.13%-12.60M

-3.15%-11.89M

1.57%-12.61M

-15.37%-12.13M

-18.82%-9.91M

-75.17%-11.53M

-47.74%-12.81M

-14.63%-10.52M

-66.08%-8.34M

13.90%-6.58M

-75.83%-8.67M

-16.36%-9.17M

---5.02M

-100.00%-7.64M

-117.70%-4.93M

-313.16%-7.88M

---3.82M

---2.27M

---1.91M

Investing cash flow

Net cash from continuing investing activities

-100.00%0.00

-45.48%205.00K

-69.17%78.00K

-79.09%161.00K

-3.33%785.00K

103.24%376.00K

289.23%253.00K

1250.88%770.00K

113.68%812.00K

-41.46%185.00K

-94.05%65.00K

-93.65%57.00K

158.50%380.00K

109.27%316.00K

106.04%1.09M

131.44%898.00K

51.55%147.00K

-33.48%151.00K

227.16%530.00K

1840.00%388.00K

-57.08%97.00K

-16.85%227.00K

--162.00K

-90.00%20.00K

25.56%226.00K

--273.00K

--200.00K

--180.00K

----

Capital expenditures

-100.00%0.00

-45.48%205.00K

-69.17%78.00K

-79.09%161.00K

-3.33%785.00K

103.24%376.00K

289.23%253.00K

1250.88%770.00K

113.68%812.00K

-41.46%185.00K

-94.05%65.00K

-93.65%57.00K

158.50%380.00K

109.27%316.00K

106.04%1.09M

131.44%898.00K

51.55%147.00K

-33.48%151.00K

227.16%530.00K

1840.00%388.00K

-57.08%97.00K

-16.85%227.00K

--162.00K

-90.00%20.00K

25.56%226.00K

--273.00K

--200.00K

--180.00K

----

Net cash flow from disposal of fixed assets

-100.00%0.00

-45.48%205.00K

-69.17%78.00K

-79.09%161.00K

-3.33%785.00K

103.24%376.00K

289.23%253.00K

1250.88%770.00K

113.68%812.00K

-41.46%185.00K

-94.05%65.00K

-93.65%57.00K

158.50%380.00K

109.27%316.00K

106.04%1.09M

131.44%898.00K

51.55%147.00K

-33.48%151.00K

227.16%530.00K

1840.00%388.00K

-57.08%97.00K

-16.85%227.00K

--162.00K

-90.00%20.00K

25.56%226.00K

--273.00K

--200.00K

--180.00K

----

Net cash flow from investment products

100.00%0.00

--50.96M

300.00%50.00M

-500.02%-50.00M

-300.14%-49.03M

----

846.25%12.50M

--12.50M

150.95%24.50M

-100.00%0.00

--1.32M

-100.00%0.00

---48.09M

150.24%25.00M

-100.00%0.00

986.96%25.00M

-100.00%0.00

-2131.18%-49.76M

-52.79%1.00M

40.85%2.30M

112.75%1.42M

--2.45M

--2.12M

--1.63M

---11.10M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

100.00%0.00

6591.72%50.96M

310.71%49.80M

-508.92%-50.08M

-307.32%-49.20M

3.33%-785.00K

967.25%12.12M

18941.54%12.25M

149.29%23.73M

-103.30%-812.00K

459.49%1.14M

-100.27%-65.00K

-5261.02%-48.14M

149.33%24.62M

-137.22%-316.00K

1250.73%23.91M

-187.44%-898.00K

-2221.16%-49.91M

-55.10%849.00K

20.33%1.77M

109.24%1.03M

1141.15%2.35M

792.67%1.89M

--1.47M

-5458.50%-11.12M

-25.56%-226.00K

---273.00K

---200.00K

---180.00K

----

Financing cash flow

Cash flow from continuous financing activities

60.63%149.99M

4677.36%25.27M

90.58%8.33M

-1235.21%-806.00K

24536.68%93.37M

-108.05%-552.00K

-95.30%4.37M

-27.55%71.00K

-99.60%379.00K

2933.19%6.86M

182.90%93.05M

--98.00K

235545.00%94.26M

343.14%226.00K

141.35%32.89M

-100.00%0.00

-99.49%40.00K

-97.64%51.00K

42487.50%13.63M

18669.63%25.34M

5386.39%7.77M

5020.45%2.17M

-99.96%32.00K

--135.00K

84.62%-147.00K

-100.09%-44.00K

191.62%73.32M

---956.00K

--49.66M

--25.14M

Net cash flow from debt Issuance/repayment

6.06%-2.82M

-673.73%-4.27M

-113.15%-1.91M

---795.00K

---3.00M

---552.00K

---897.00K

----

Net cash flow from common stock issuance/repurchase

58.68%152.61M

--29.51M

97.89%10.15M

---25.00K

--96.18M

--0.00

-94.41%5.13M

100.00%0.00

----

179.22%91.74M

---141.00K

--93.60M

----

142.60%32.85M

-100.00%0.00

1354400.00%13.54M

--24.88M

5314.29%7.67M

5020.45%2.17M

-100.00%-1.00K

--0.00

---147.00K

---44.00K

--71.21M

----

--0.00

----

Net cash flow from preferred stock issuance/repurchase

----

100.00%0.00

-100.00%0.00

---1.08M

--49.78M

--25.14M

Proceeds from stock option exercised by employees

-1.52%194.00K

--32.00K

-32.86%94.00K

-80.28%14.00K

-48.02%197.00K

-100.00%0.00

-89.31%140.00K

-70.29%71.00K

-10.19%379.00K

142.14%1.11M

3538.89%1.31M

--239.00K

955.00%422.00K

798.04%458.00K

-57.65%36.00K

-100.00%0.00

-62.26%40.00K

--51.00K

157.58%85.00K

240.00%459.00K

--106.00K

----

450.00%33.00K

--135.00K

----

--6.00K

----

Net cash flow from other financing activities

--140.36M

--0.00

----

2576.72%5.75M

----

--232.00K

---232.00K

----

100.00%0.00

--2.10M

--121.00K

---121.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

60.63%149.99M

4677.36%25.27M

90.58%8.33M

-1235.21%-806.00K

24536.68%93.37M

-108.05%-552.00K

-95.30%4.37M

-27.55%71.00K

-99.60%379.00K

2933.19%6.86M

182.90%93.05M

--98.00K

235545.00%94.26M

343.14%226.00K

141.35%32.89M

-100.00%0.00

-99.49%40.00K

-97.64%51.00K

42487.50%13.63M

18669.63%25.34M

5386.39%7.77M

5020.45%2.17M

-99.96%32.00K

--135.00K

84.62%-147.00K

-100.09%-44.00K

191.62%73.32M

---956.00K

--49.66M

--25.14M

Net cash flow

Beginning cash balance

-11.53%116.64M

-49.39%82.98M

-64.71%60.21M

-18.48%145.61M

-24.79%131.83M

-15.15%163.96M

47.71%170.61M

39.46%178.61M

86.79%175.29M

136.79%193.24M

88.84%115.50M

171.52%128.07M

57.58%93.84M

-33.23%81.61M

-48.28%61.16M

-52.59%47.17M

-38.78%59.55M

20.50%122.22M

8.82%118.26M

-11.24%99.50M

-25.74%97.28M

-25.53%101.43M

52.98%108.68M

--112.10M

63.27%131.00M

312.53%136.20M

626.17%71.04M

--80.23M

--33.02M

--9.78M

Current period cash flow changes

687.01%108.47M

204.73%33.65M

442.70%22.78M

-966.91%-85.41M

315.12%13.78M

-79.06%-32.13M

-108.55%-6.65M

36.32%-8.01M

-90.30%3.32M

-246.63%-17.95M

280.24%77.74M

-189.83%-12.57M

376.38%34.23M

119.53%12.24M

416.00%20.44M

-25.42%13.99M

-658.34%-12.38M

-1409.37%-62.67M

154.65%3.96M

649.01%18.77M

111.73%2.22M

20.17%-4.15M

-111.13%-7.25M

---3.42M

-279.87%-18.91M

-111.01%-5.20M

180.46%65.16M

---4.98M

--47.22M

--23.23M

Effect of exchange rate changes

-122.58%-7.00K

-285.71%-13.00K

60.00%-8.00K

---11.00K

--31.00K

--7.00K

---20.00K

----

Ending cash balance

54.59%225.10M

-11.53%116.64M

-49.39%82.98M

-64.71%60.21M

-18.48%145.61M

-24.79%131.83M

-15.15%163.96M

47.71%170.61M

39.46%178.61M

86.79%175.29M

136.79%193.24M

88.84%115.50M

171.52%128.07M

57.58%93.84M

-33.23%81.61M

-48.28%61.16M

-52.59%47.17M

-38.78%59.55M

20.50%122.22M

8.82%118.26M

-11.24%99.50M

-25.74%97.28M

-25.53%101.43M

--108.68M

48.95%112.10M

63.27%131.00M

312.53%136.20M

--75.26M

--80.23M

--33.02M

Free cash flow

-35.72%-41.51M

-34.74%-42.56M

-51.28%-35.55M

-68.09%-34.59M

-41.88%-30.59M

-27.37%-31.59M

-41.27%-23.50M

-62.41%-20.58M

-80.47%-21.56M

-90.95%-24.80M

-33.63%-16.63M

-15.11%-12.67M

3.85%-11.95M

-0.25%-12.99M

-16.70%-12.45M

-24.03%-11.01M

-78.30%-12.42M

-47.78%-12.96M

-13.47%-10.67M

-71.11%-8.87M

9.06%-6.97M

-70.00%-8.77M

-15.25%-9.40M

---5.19M

-90.55%-7.66M

-110.92%-5.16M

---8.16M

---4.02M

---2.44M

----

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Cabaletta Bio Inc Generate?



Cabaletta Bio Inc generated -131.08M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Cabaletta Bio Inc's Operating Cash Flow Change Year Over Year?



Cabaletta Bio Inc's operating cash flow increased by -48.58% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Cabaletta Bio Inc Spend on Capital Expenditures?



Cabaletta Bio Inc spent 1.23M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Cabaletta Bio Inc's Financing Cash Flow Changed?



Cabaletta Bio Inc used 100.35M in financing activities in the latest quarter.

What is free cash flow and why does it matter for CABA?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Cabaletta Bio Inc’s free cash flow in the latest quarter?



Free cash flow was -132.31M reflecting a -46.31% change from the previous year.